GEODE CAPITAL MANAGEMENT, LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,712,352
+29.9%
1,783,701
+1.5%
0.00%
Q1 2023$1,318,077
+236538.6%
1,757,437
+16.2%
0.00%
Q4 2022$557
-99.9%
1,512,202
-2.5%
0.00%
Q3 2022$667,000
-50.7%
1,551,752
-10.6%
0.00%
Q2 2022$1,353,000
-61.5%
1,735,725
-36.4%
0.00%
Q1 2022$3,518,000
+9.8%
2,727,532
+8.1%
0.00%
Q4 2021$3,205,000
-45.3%
2,523,635
-6.1%
0.00%
-100.0%
Q3 2021$5,856,000
-41.0%
2,686,533
+1.5%
0.00%0.0%
Q2 2021$9,927,000
+26.7%
2,647,265
+10.2%
0.00%0.0%
Q1 2021$7,834,000
+5.1%
2,403,244
+9.9%
0.00%0.0%
Q4 2020$7,456,000
-7.6%
2,186,700
+10.6%
0.00%
-50.0%
Q3 2020$8,067,000
+42.9%
1,977,342
+18.4%
0.00%
+100.0%
Q2 2020$5,644,000
+51.4%
1,670,110
+4.4%
0.00%0.0%
Q1 2020$3,728,000
-66.8%
1,600,076
-48.1%
0.00%0.0%
Q4 2019$11,220,000
-8.0%
3,082,854
+109.6%
0.00%
-66.7%
Q3 2019$12,200,000
+0.2%
1,470,883
+4.1%
0.00%0.0%
Q2 2019$12,170,000
-10.9%
1,413,573
+10.7%
0.00%
-25.0%
Q1 2019$13,653,000
-32.5%
1,277,261
-44.8%
0.00%
+33.3%
Q4 2018$20,232,000
+17.5%
2,312,238
+125.5%
0.00%
-40.0%
Q3 2018$17,226,000
-15.1%
1,025,404
+5.9%
0.01%
-16.7%
Q2 2018$20,300,000
+52.3%
968,536
+16.9%
0.01%
+50.0%
Q1 2018$13,332,000
-13.3%
828,643
+2.1%
0.00%
-20.0%
Q4 2017$15,384,000
+67.0%
811,847
+24.0%
0.01%
+66.7%
Q3 2017$9,211,000
+106.9%
654,717
+9.6%
0.00%
+50.0%
Q2 2017$4,451,000
+25.6%
597,557
+9.6%
0.00%
+100.0%
Q1 2017$3,543,000
+55.5%
545,118
+6.0%
0.00%0.0%
Q4 2016$2,278,000
+0.8%
514,469
+6.3%
0.00%0.0%
Q3 2016$2,259,000
-14.1%
483,907
+20.9%
0.00%0.0%
Q2 2016$2,630,000
+5.1%
400,313
+1.7%
0.00%0.0%
Q1 2016$2,503,000
+6.5%
393,699
+0.9%
0.00%0.0%
Q4 2015$2,351,000
+3.1%
390,000
+2.2%
0.00%0.0%
Q3 2015$2,281,000
-12.0%
381,495
+0.6%
0.00%0.0%
Q2 2015$2,591,000
+23.4%
379,056
+9.6%
0.00%0.0%
Q1 2015$2,099,000
-8.7%
345,957
+4.3%
0.00%0.0%
Q4 2014$2,298,000
-5.1%
331,668
+11.5%
0.00%
-50.0%
Q3 2014$2,421,000
+2.2%
297,510
+2.1%
0.00%0.0%
Q2 2014$2,369,000
+5.9%
291,503
+2.1%
0.00%0.0%
Q1 2014$2,237,000
-8.2%
285,424
+3.7%
0.00%0.0%
Q4 2013$2,436,000
+7.7%
275,361
+2.2%
0.00%0.0%
Q3 2013$2,261,000
+40.1%
269,494
+24.5%
0.00%
+100.0%
Q2 2013$1,614,000216,4070.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders